Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice
Introduction - Heterotopic ossification (HO) occurs following orthopedic trauma, spinal cord injuries, brain trauma and limb amputations. Once symptomatic, HO causes pain, limited mobility and decreased quality of life. Current treatments are limited and have significant complications with high recu...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 November 2024
|
| In: |
Frontiers in Bioengineering and Biotechnology
Year: 2024, Jahrgang: 12, Pages: 1-12 |
| ISSN: | 2296-4185 |
| DOI: | 10.3389/fbioe.2024.1491962 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fbioe.2024.1491962 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.orghttps://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2024.1491962/full 
|
| Verfasserangaben: | Cameron Rementer, Apichai Yavirach, Worakanya Buranaphatthana, Philip A. Walczak, Mei Speer, Kat Pierce, Subramanian Dharmarajan, Elizabeth Leber, Bruce Sangiorzan, Steven Bain, Marta Scatena, Alexander Blümke and Cecilia M. Giachelli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1923046055 | ||
| 003 | DE-627 | ||
| 005 | 20250717010413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250416s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fbioe.2024.1491962 |2 doi | |
| 035 | |a (DE-627)1923046055 | ||
| 035 | |a (DE-599)KXP1923046055 | ||
| 035 | |a (OCoLC)1528044521 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rementer, Cameron |e VerfasserIn |0 (DE-588)1363192612 |0 (DE-627)1923046624 |4 aut | |
| 245 | 1 | 0 | |a Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice |c Cameron Rementer, Apichai Yavirach, Worakanya Buranaphatthana, Philip A. Walczak, Mei Speer, Kat Pierce, Subramanian Dharmarajan, Elizabeth Leber, Bruce Sangiorzan, Steven Bain, Marta Scatena, Alexander Blümke and Cecilia M. Giachelli |
| 264 | 1 | |c 22 November 2024 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.04.2025 | ||
| 520 | |a Introduction - Heterotopic ossification (HO) occurs following orthopedic trauma, spinal cord injuries, brain trauma and limb amputations. Once symptomatic, HO causes pain, limited mobility and decreased quality of life. Current treatments are limited and have significant complications with high recurrence rates, underscoring the need for improved therapeutic interventions. Osteoclasts (OCs) are physiological bone resorptive cells that secrete enzymes and protons to degrade bone. - - Methods - In this study, we describe the use of genetically engineered OCs as a novel cell therapy approach to treat HO. Inducible, engineered myeloid precursors (iRANK cells) treated with a chemical inducer of dimerization (CID) differentiated into TRAP+ multinucleated OCs and resorbed mineralized tissues in vitro. - - Results - In vivo, BMP-2-induced murine HO lesions were significantly regressed following treatment using iRANK cells with concomitant systemic administration of CID. Moreover, many OCs were TRAP+, MMP9+, and GFP+, indicating that they differentiated from delivered iRANK cells. - - Discussion - In summary, these data con rm the ability of engineered myeloid precursors to differentiate into OCs and resorb HO in vivo paving the way for OC delivery as a promising approach for HO treatment. | ||
| 650 | 4 | |a Chemical inducer of dimerization | |
| 650 | 4 | |a Engineered Osteoclasts | |
| 650 | 4 | |a heterotopic ossification | |
| 650 | 4 | |a Osteoclasts | |
| 650 | 4 | |a Rank | |
| 650 | 4 | |a Resorption | |
| 700 | 1 | |a Yavirach, Apichai |e VerfasserIn |4 aut | |
| 700 | 1 | |a Buranaphatthana, Worakanya |e VerfasserIn |4 aut | |
| 700 | 1 | |a Walczak, Philip A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Speer, Mei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pierce, Kat |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dharmarajan, Subramanian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leber, Elizabeth |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sangiorzan, Bruce |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bain, Steven |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scatena, Marta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blümke, Alexander Felix |e VerfasserIn |0 (DE-588)1341270653 |0 (DE-627)1902121325 |4 aut | |
| 700 | 1 | |a Giachelli, Cecilia M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in Bioengineering and Biotechnology |d Lausanne : Frontiers Media, 2013 |g 12(2024), Seite 1-12 |h Online-Ressource |w (DE-627)74950403X |w (DE-600)2719493-0 |w (DE-576)383523621 |x 2296-4185 |7 nnas |a Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g pages:1-12 |g extent:12 |a Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fbioe.2024.1491962 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.orghttps://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2024.1491962/full |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250416 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1341270653 |a Blümke, Alexander Felix |m 1341270653:Blümke, Alexander Felix |d 60000 |d 62400 |e 60000PB1341270653 |e 62400PB1341270653 |k 0/60000/ |k 1/60000/62400/ |p 12 | ||
| 999 | |a KXP-PPN1923046055 |e 4705995023 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice","title_sort":"Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in mice"}],"person":[{"role":"aut","display":"Rementer, Cameron","roleDisplay":"VerfasserIn","given":"Cameron","family":"Rementer"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Yavirach, Apichai","given":"Apichai","family":"Yavirach"},{"given":"Worakanya","family":"Buranaphatthana","role":"aut","display":"Buranaphatthana, Worakanya","roleDisplay":"VerfasserIn"},{"display":"Walczak, Philip A.","roleDisplay":"VerfasserIn","role":"aut","family":"Walczak","given":"Philip A."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Speer, Mei","given":"Mei","family":"Speer"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Pierce, Kat","given":"Kat","family":"Pierce"},{"family":"Dharmarajan","given":"Subramanian","display":"Dharmarajan, Subramanian","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Leber, Elizabeth","roleDisplay":"VerfasserIn","given":"Elizabeth","family":"Leber"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Sangiorzan, Bruce","given":"Bruce","family":"Sangiorzan"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bain, Steven","given":"Steven","family":"Bain"},{"family":"Scatena","given":"Marta","display":"Scatena, Marta","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Alexander Felix","family":"Blümke","role":"aut","roleDisplay":"VerfasserIn","display":"Blümke, Alexander Felix"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Giachelli, Cecilia M.","given":"Cecilia M.","family":"Giachelli"}],"language":["eng"],"recId":"1923046055","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 16.04.2025"],"id":{"eki":["1923046055"],"doi":["10.3389/fbioe.2024.1491962"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"22 November 2024"}],"name":{"displayForm":["Cameron Rementer, Apichai Yavirach, Worakanya Buranaphatthana, Philip A. Walczak, Mei Speer, Kat Pierce, Subramanian Dharmarajan, Elizabeth Leber, Bruce Sangiorzan, Steven Bain, Marta Scatena, Alexander Blümke and Cecilia M. Giachelli"]},"relHost":[{"origin":[{"publisher":"Frontiers Media","dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisherPlace":"Lausanne"}],"id":{"eki":["74950403X"],"zdb":["2719493-0"],"issn":["2296-4185"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Frontiers in Bioengineering and Biotechnology","title":"Frontiers in Bioengineering and Biotechnology"}],"pubHistory":["2013 -"],"titleAlt":[{"title":"FBIOE"}],"part":{"pages":"1-12","year":"2024","extent":"12","text":"12(2024), Seite 1-12","volume":"12"},"disp":"Engineered myeloid precursors differentiate into osteoclasts and resorb heterotopic ossification in miceFrontiers in Bioengineering and Biotechnology","note":["Gesehen am 04.06.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"74950403X"}],"physDesc":[{"extent":"12 S."}]} | ||
| SRT | |a REMENTERCAENGINEERED2220 | ||